Insider Trading & Ownership of Arpa Garay

Location
Kenilworth, NJ
Summary
The estimated net worth of Arpa Garay is at least $2,010,170 dollars as of 07 Dec 2023. Arpa Garay is the Chief Commercial Officer of Moderna, Inc. and owns shares of Moderna, Inc. (MRNA) stock worth about $1.52M. Arpa Garay is the SVP Human Health Global Mktg. of Merck & Co., Inc. and owns shares of Merck & Co., Inc. (MRK) stock worth about $486.2K.
Signature
/s/ James Dillon, as Attorney-in-Fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Arpa Garay and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Quick Takeaways

  • Arpa Garay has 2 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $2,010,170.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Moderna, Inc. ($1,524,005).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Arpa Garay

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
MRNA Moderna, Inc. Chief Commercial Officer $1,524,005 05 Dec 2023
MRK Merck & Co., Inc. SVP Human Health Global Mktg. $486,165 03 May 2022

Insider Transactions Reported by Arpa Garay:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .